Publications | The Journal of Infectious Diseases | Advanced Search for Research Outcomes

The following results are related to COVID-19. Are you interested to view more results? Visit OpenAIRE - Explore.

Results per page:

Sort by:

Download Results

777 research outcomes, page 1 of 78

publication . Article . Preprint . 2022
Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2
Embargo
Authors:
Martin Šmíd; Luděk Berec; Lenka Přibylová; Ondřej Májek; Tomáš Pavlík; Jiří Jarkovský; Jakub Weiner; Tamara Barusová; Jan Trnka;
Persistent Identifiers
doi: 10.1093/infdis/jiac161 , 10.1101/2022.02.24.22271396
Publisher: Oxford University Press (OUP)
The Omicron variant of the SARS-CoV-2 virus carries mutations, which enable it to evade immunity conferred by vaccines and previous infections. We used a Cox proportional hazards model and a logistic regression model on individual-level data on all laboratory-confirmed ...
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.
publication . Article . 2022
As well as Omicron BA.1, high neutralizing activity against Omicron BA.2 can be induced by COVID-19 mRNA booster vaccination
Embargo
Authors:
Lidya Handayani Tjan; Koichi Furukawa; Yukiya Kurahashi; Silvia Sutandhio; Mitsuhiro Nishimura; Jun Arii; Yasuko Mori;
Persistent Identifiers
doi: 10.1093/infdis/jiac159
Publisher: Oxford University Press (OUP)
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.
publication . Article . 2022
Protection of Hamsters Challenged with SARS-CoV-2 Delta Variant after Two Doses of Adjuvanted SARS-CoV-2 Stabilized Prefusion Spike Protein (S-2P) and a Single Dose of Beta Variant S-2P
Open Access
Authors:
Tsun-Yung Kuo; Chia En Lien; Yi-Jiun Lin; Meei-Yun Lin; Chung-Chin Wu; Wei-Hsuan Tang; John D. Campbell; Paula Traquina; Ya-Shan Chuang; Luke Tzu-Chi Liu; ...
Persistent Identifiers
doi: 10.1093/infdis/jiac153
Publisher: Oxford University Press (OUP)
Abstract SARS-CoV-2 Variants of Concern (VoCs) negatively impact the effectiveness of vaccines. In this study, we challenge hamsters with the Delta variant after two- or three-dose inoculations with SARS-CoV-2 vaccines constructed from stabilized prefusion spike protein...
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.
publication . Article . 2022
B cell responses in hospitalized SARS-CoV-2-infected children with and without Multisystem Inflammatory Syndrome
Embargo
Authors:
Nadine Peart Akindele; Lisa Pieterse; San Suwanmanee; Diane E Griffin;
Persistent Identifiers
doi: 10.1093/infdis/jiac119
Publisher: Oxford University Press (OUP)
Abstract Multisystem inflammatory syndrome in children (MIS-C) can complicate infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but differences in the immune responses during MIS-C compared to coronavirus disease 2019 (COVID-19) are poorly und...
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.
publication . Article . 2022
Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review
Embargo
Authors:
Chen Chen; Spencer R. Haupert; Lauren Zimmermann; Xu Shi; Lars G. Fritsche; Bhramar Mukherjee;
Persistent Identifiers
doi: 10.1093/infdis/jiac136
Publisher: Oxford University Press (OUP)
Abstract Introduction This study aims to examine the worldwide prevalence of post COVID-19 condition, through a systematic review and meta-analysis. Methods PubMed, Embase, and iSearch were searched on July 5, 2021 with verification extending to March 13, 2022. Using...
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.
publication . Article . 2022
Breakthrough gastrointestinal COVID and intra-host evolution consequent to combination monoclonal antibody prophylaxis
Embargo
Authors:
Brandon J. Beddingfield; Lori A. Rowe; Kasi E. Russell-Lodrigue; Lara A. Doyle-Meyers; Nadia Golden; Skye Spencer; Nicole Chirichella; Robert V. Blair; Nicholas J. Maness; Chad J. Roy;
Persistent Identifiers
doi: 10.1093/infdis/jiac134
Publisher: Oxford University Press (OUP)
Abstract Breakthrough gastrointestinal COVID was observed after experimental SARS-CoV-2 upper mucosal infection in a rhesus macaque undergoing low-dose monoclonal antibody prophylaxis. High levels of viral RNA were detected in intestinal sites contrasting with minimal v...
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.
publication . Article . 2022
Impact of preexisting anti-Ad26 humoral immunity on immunogenicity of the Ad26.COV2.S COVID-19 vaccine
Open Access
Authors:
Mathieu Le Gars; Jerald Sadoff; Frank Struyf; Dirk Heerwegh; Carla Truyers; Jenny Hendriks; Glenda Gray; Beatriz Grinsztejn; Paul A. Goepfert; Hanneke Schuitemaker; ...
Persistent Identifiers
doi: 10.1093/infdis/jiac142
Publisher: Oxford University Press (OUP)
Abstract This secondary analysis of the phase 3 ENSEMBLE trial (NCT04505722) assessed the impact of preexisting humoral immunity to adenovirus type 26 (Ad26) on the immunogenicity of Ad26.COV2.S-elicited SARS-CoV-2–specific antibody levels in 380 participants in Brazil,...
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.
publication . Article . 2022
mRNA Vaccine Effectiveness Against COVID-19 Hospitalization Among Solid Organ Transplant Recipients
Embargo
Authors:
Shekhar Ghamande; Nicholas Mohr;
Persistent Identifiers
doi: 10.1093/infdis/jiac118
Publisher: Oxford University Press (OUP)
Abstract Background The study objective was to evaluate 2 and 3 dose COVID-19 mRNA vaccine effectiveness (VE) in preventing COVID-19 hospitalization among adult solid organ transplant (SOT) recipients. Methods 21-site case-control analysis of 10,425 adults hospitaliz...
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.
publication . Article . 2022
Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine
Embargo
Authors:
Jenny S Maron; Michelle Conroy; Vivek Naranbai; Upeka Samarakoon; Tina Motazedi; Jocelyn R Farmer; Esther Freeman; Aleena Banerji; Yannic C Bartsch; David J Gregory; ...
Persistent Identifiers
doi: 10.1093/infdis/jiac107
Publisher: Oxford University Press (OUP)
Abstract Allergic symptoms after messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccines occur in up to 2% of recipients. Compared to nonallergic controls (n = 18), individuals with immediate allergic reactions to mRNA COVID-19 vaccines (n = 8) mounted lower i...
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.
publication . Article . 2022
Autoantibodies and COVID-19:  Rediscovering Nonspecific Polyclonal B-Cell Activation?
Embargo
Authors:
Nevio Cimolai;
Persistent Identifiers
doi: 10.1093/infdis/jiac105
Publisher: Oxford University Press (OUP)
Add to ORCID
Please grant OpenAIRE to access and update your ORCID works.
This research outcome is the result of merged research outcomes in OpenAIRE.

You have already added works in your ORCID record related to the merged research outcome.

777 research outcomes, page 1 of 78

Field to search	Term
All fields		Add rule

Filters

COVID-19 Publications The Journal of Infectious Diseases

Access (2)

Type (4)

Year range

Document Type (3)

Field of Science (27)

Funder (8)

SDG (11)

Country (100)

Language (2)

Source (54)

Research Community (10)

Filters

COVID-19 Publications The Journal of Infectious Diseases

Access (2)

Type (4)

Year range

Document Type (3)

Field of Science (27)

Funder (8)

SDG (11)

Country (100)

Language (2)

Source (54)

Research Community (10)

Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2

As well as Omicron BA.1, high neutralizing activity against Omicron BA.2 can be induced by COVID-19 mRNA booster vaccination

Protection of Hamsters Challenged with SARS-CoV-2 Delta Variant after Two Doses of Adjuvanted SARS-CoV-2 Stabilized Prefusion Spike Protein (S-2P) and a Single Dose of Beta Variant S-2P

B cell responses in hospitalized SARS-CoV-2-infected children with and without Multisystem Inflammatory Syndrome

Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review

Breakthrough gastrointestinal COVID and intra-host evolution consequent to combination monoclonal antibody prophylaxis

Impact of preexisting anti-Ad26 humoral immunity on immunogenicity of the Ad26.COV2.S COVID-19 vaccine

mRNA Vaccine Effectiveness Against COVID-19 Hospitalization Among Solid Organ Transplant Recipients

Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine

Autoantibodies and COVID-19:  Rediscovering Nonspecific Polyclonal B-Cell Activation?

Advanced search in Research outcomes

Filters

COVID-19 Publications The Journal of Infectious Diseases

Access (2)

Type (4)

Year range

Document Type (3)

Field of Science (27)

Funder (8)

SDG (11)

Country (100)

Language (2)

Source (54)

Research Community (10)

Filters

COVID-19 Publications The Journal of Infectious Diseases

Access (2)

Type (4)

Year range

Document Type (3)

Field of Science (27)

Funder (8)

SDG (11)

Country (100)

Language (2)

Source (54)

Research Community (10)

Advanced search in
Research outcomes